News and Press Releases

Deerland Probiotics & Enzymes Announces Acquisition of Bifodan A/S

Deerland Probiotics & Enzymes Announces Acquisition of Bifodan A/S

KENNESAW, GA (October 31, 2019) – Deerland Probiotics & Enzymes, a US-based supplier of sciencebacked solutions for microbiome health, announced today its acquisition of Bifodan A/S. Bifodan, based in Hundested, Denmark, is a life science company specialized in developing, manufacturing and distributing unique probiotic product solutions as private label dietary supplements, medical devices and OTC drugs.

read more

Probiotic Research Initiative

Bifodan A/S together with Aalborg University is pleased to announce the foundation of the Probiotic Research InitiativeTM. Probiotic Research InitiativeTM is a collaboration between Bifodan and the Biomedicine Group at Aalborg University to enhance the effectiveness of research across academia and industry related to the application of probiotics in health and disease.

read more

New Publication on LB Rhamnosus PB01

New Publication on LB Rhamnosus PB01 FOR IMMEDIATE RELASE. Copenhagen, Denmark, December 12th 2016 – Bifodan A/S is pleased to announce the publication of new and promising scientific evidence on its proprietary strain, Lactobacillus Rhamnosus PB01, and...

read more

Bifodan Scientific Advisory Board

Bifodan Scientific Advisory Board FOR IMMEDIATE RELASE. Copenhagen, Denmark / Massachusetts, USA, September 7th 2016 – Bifodan, manufacturer of private label probiotic finished solutions for the nutritional industry, is proud to present its newly...

read more

FastMelt Immuno

FastMelt Immuno FOR IMMEDIATE RELASE. Bifodan A/S Announces Release of FastMelt Immuno Copenhagen, Denmark, May 4th 2015 – Bifodan A/S, a distinct partner in probiotic finished solutions for the private label industry, announces the market introduction of...

read more

Ecovag®

Ecovag® Copenhagen, Denmark, January 14, 2015 – Bifodan A/S, the Danish based, - specialized provider of innovative probiotic solutions, - announces the establishment of a separate Business Unit for its Ecovag® probiotic activities targeting women’s...

read more